VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WATWaters Corporation
$374.41$24.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksWATFinancials

Waters Corporation (WAT) Financials

30Y historyFree accessUpdated daily

Operating performance deteriorated sharply in 2026Q1, with gross margins contracting to 47.0% and operating income falling to a $47.0 million loss.

WAT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue3.77B3.17B2.96B2.96B2.97B2.79B2.37B2.41B2.42B2.31B2.17B2.04B1.99B1.9B1.84B1.85B1.64B1.5B1.58B1.47B1.28B1.16B1.1B958.21M889.97M859.21M795.07M704.4M618.8M465.5M391.1M
Revenue Growth %26.39%6.99%0.07%-0.52%6.68%17.78%-1.71%-0.55%4.8%6.54%6.12%2.66%4.47%3.29%-0.41%12.65%9.65%-4.85%6.93%15.06%10.53%4.86%15.27%7.67%3.58%8.07%12.87%13.83%32.93%19.02%17.45%
Cost of Goods Sold1.7B1.34B1.2B1.2B1.25B1.16B1.01B1.01B992.56M947.07M891.45M842.67M824.91M783.46M737.61M730.49M653.3M594.88M661.27M631.12M536.18M478.36M454.81M397.85M373.47M311.23M265.9M235.6M213.4M158.7M133.6M
COGS % of Revenue-42.23%40.57%40.43%42%41.51%42.56%42%41.02%41.01%41.13%41.26%41.47%41.14%40.01%39.46%39.75%39.69%41.98%42.84%41.88%41.3%41.18%41.52%41.96%36.22%33.44%33.45%34.49%34.09%34.16%
Gross Profit2.07B1.83B1.76B1.76B1.72B1.63B1.36B1.4B1.43B1.36B1.28B1.2B1.16B1.12B1.11B1.12B990.07M903.82M913.86M841.93M744.04M679.88M649.73M560.36M516.5M547.98M529.17M468.8M405.4M306.8M257.5M
Gross Margin %55.02%57.77%59.43%59.57%58%58.49%57.44%58%58.98%58.99%58.87%58.74%58.53%58.86%59.99%60.54%60.25%60.31%58.02%57.16%58.12%58.7%58.82%58.48%58.04%63.78%66.56%66.55%65.51%65.91%65.84%
Gross Profit Growth %-4.01%-0.17%2.17%5.8%19.92%-2.67%-2.2%4.8%6.74%6.36%3.03%3.9%1.33%-1.31%13.19%9.54%-1.1%8.54%13.16%9.44%4.64%15.95%8.49%-5.74%3.55%12.88%15.64%32.14%19.15%15.32%
Operating Expenses1.43B935.45M931.83M943.52M850.38M807.63M713.19M687.44M687.59M699.81M650.93M632.21M646.52M603.42M594.54M592.09M540.14M509.22M524.1M493.05M448.89M396.73M364.87M341.19M320.09M398.45M318.34M292.3M269M269.2M187.2M
OpEx % of Revenue-29.55%31.5%31.91%28.61%28.99%30.15%28.56%28.41%30.31%30.03%30.96%32.5%31.69%32.25%31.98%32.87%33.98%33.27%33.47%35.06%34.25%33.03%35.61%35.97%46.37%40.04%41.5%43.47%57.83%47.87%
Selling, General & Admin1.01B740.27M690.15M736.01M658.03M626.97M553.7M534.79M536.9M544.36M512.33M495.75M512.71M492.96M477.27M490.01M445.46M421.4M433.23M403.7M357.66M321.69M300.15M264.25M246.82M269.71M246.39M226.6M206.2M167.3M148.5M
SG&A % of Revenue-23.39%23.33%24.9%22.14%22.51%23.41%22.22%22.19%23.57%23.64%24.27%25.77%25.89%25.89%26.47%27.11%28.12%27.5%27.41%27.94%27.77%27.17%27.58%27.73%31.39%30.99%32.17%33.32%35.94%37.97%
Research & Development248.29M195.18M183.03M174.94M176.19M168.36M140.78M142.96M143.4M132.59M125.19M118.55M107.73M100.54M96M92.35M84.27M77.15M81.59M80.65M77.31M66.91M65.24M59.24M51.92M46.6M42.51M36.1M34.4M80.8M20.9M
R&D % of Revenue-6.17%6.19%5.92%5.93%6.04%5.95%5.94%5.93%5.74%5.78%5.8%5.42%5.28%5.21%4.99%5.13%5.15%5.18%5.47%6.04%5.78%5.91%6.18%5.83%5.42%5.35%5.12%5.56%17.36%5.34%
Other Operating Expenses3M058.66M32.56M16.16M12.31M18.71M9.69M7.29M22.86M13.41M17.92M26.09M9.92M21.26M9.73M10.41M10.66M9.29M8.7M13.92M8.13M-520K17.69M21.35M82.14M29.44M29.6M28.4M21.1M17.8M
Operating Income643.9M893.22M826.35M817.68M873.39M821.71M645.49M708.46M739.77M662.2M625.04M567.45M517.91M517.34M511.49M528.6M449.93M394.6M389.75M348.88M295.15M283.15M284.86M219.17M196.41M149.53M210.83M176.5M136.4M37.6M70.3M
Operating Margin %17.08%28.22%27.93%27.66%29.39%29.5%27.29%29.44%30.57%28.68%28.84%27.78%26.03%27.17%27.74%28.55%27.38%26.33%24.74%23.68%23.05%24.45%25.79%22.87%22.07%17.4%26.52%25.06%22.04%8.08%17.97%
Operating Income Growth %-8.09%1.06%-6.38%6.29%27.3%-8.89%-4.23%11.71%5.95%10.15%9.57%0.11%1.14%-3.24%17.48%14.02%1.24%11.72%18.2%4.24%-0.6%29.97%11.59%31.35%-29.08%19.45%29.4%262.77%-46.51%24.65%
EBITDA952.77M1.1B1.02B983.58M1B953.39M770.85M813.75M848.18M768.2M721.49M657.44M612.14M597.04M580.32M594.99M512.49M451.87M455.02M402.2M341.31M326.84M326.78M253.02M233.6M183.48M240.26M206.1M164.8M58.7M88.1M
EBITDA Margin %25.27%34.73%34.42%33.27%33.78%34.22%32.59%33.81%35.05%33.27%33.29%32.19%30.77%31.35%31.48%32.14%31.19%30.15%28.89%27.3%26.66%28.22%29.59%26.41%26.25%21.35%30.22%29.26%26.63%12.61%22.53%
EBITDA Growth %-8.12%7.98%3.52%-2.02%5.29%23.68%-5.27%-4.06%10.41%6.47%9.74%7.4%2.53%2.88%-2.46%16.1%13.41%-0.69%13.14%17.84%4.43%0.02%29.15%8.31%27.32%-23.63%16.58%25.06%180.75%-33.37%20.85%
D&A (Non-Cash Add-back)308.87M206.24M191.82M165.91M130.42M131.68M125.36M105.3M108.41M106M96.45M89.99M94.23M79.69M68.83M66.39M62.56M57.27M65.27M53.32M46.16M43.69M41.93M33.85M37.19M33.95M29.44M29.6M28.4M21.1M17.8M
EBIT615.6M805.65M844.54M835.1M886.64M851.13M659.98M726.93M730.79M697.94M645.02M578.16M524.93M520.15M515.7M531.22M451.79M397.64M410.71M348.88M303.63M283.15M284.8M220.09M203.81M149.53M210.83M176.5M136.4M37.6M70.3M
Net Interest Income-82.39M-50.77M-72.26M-82.24M-37.78M-32.72M-32.8M-26.63M-9.83M-20.76M-24.23M-25.53M-27.17M-25.66M-23.86M-19.35M-12.07M-7.95M-17.56M000000000000
Interest Income9.22M017.42M16.62M11.02M12.22M16.27M22.06M38.81M36.08M20.69M10.71M7.02M4.39M4.21M2.62M1.85M3.04M20.96M000000000000
Interest Expense91.61M50.77M89.68M98.86M48.8M44.94M49.07M48.69M48.64M56.84M44.91M36.24M34.19M30.05M28.07M21.97M13.92M10.99M38.52M000000000000
Other Income/Expense-119.91M-138.34M-71.48M-81.43M-35.55M-15.51M-34.58M-30.22M-57.63M-21.1M-24.93M-25.53M-27.17M-27.24M-23.86M-19.35M-12.07M-7.95M-17.56M-25.69M-36.78M-8.59M813K4.51M-1M-2.1M135K-9M-34.9M-30.1M-39.2M
Pretax Income523.99M754.88M754.87M736.24M837.85M806.19M610.91M678.24M682.15M641.1M600.11M541.92M490.74M490.11M487.63M509.25M437.86M386.65M372.19M323.19M262.96M274.56M285.67M223.69M195.41M147.43M210.96M167.5M101.5M7.5M31.1M
Pretax Margin %13.9%23.85%25.52%24.9%28.19%28.94%25.83%28.18%28.19%27.76%27.69%26.53%24.67%25.74%26.45%27.51%26.64%25.8%23.63%21.94%20.54%23.71%25.86%23.34%21.96%17.16%26.53%23.78%16.4%1.61%7.95%
Income Tax74.74M112.25M117.03M94.01M130.09M113.35M89.34M86.04M88.35M620.79M78.61M72.87M59.12M40.1M26.18M76.28M56.1M63.34M49.71M55.12M40.76M72.59M61.62M52.8M43.19M32.88M54.85M45.2M27.1M15.8M11.2M
Effective Tax Rate %14.26%14.87%15.5%12.77%15.53%14.06%14.62%12.69%12.95%96.83%13.1%13.45%12.05%8.18%5.37%14.98%12.81%16.38%13.36%17.05%15.5%26.44%21.57%23.6%22.1%22.3%26%26.99%26.7%210.67%36.01%
Net Income449.25M642.63M637.83M642.23M707.75M692.84M521.57M592.2M593.79M20.31M521.5M469.05M431.62M450M461.44M432.97M381.76M323.31M322.48M268.07M222.2M201.97M224.05M170.89M147.71M114.54M145.34M122.3M74.4M-8.3M-2.4M
Net Margin %11.91%20.3%21.56%21.72%23.81%24.87%22.05%24.61%24.54%0.88%24.06%22.97%21.7%23.63%25.03%23.39%23.23%21.57%20.47%18.2%17.36%17.44%20.28%17.83%16.6%13.33%18.28%17.36%12.02%-1.78%-0.61%
Net Income Growth %-31.62%0.75%-0.69%-9.26%2.15%32.84%-11.93%-0.27%2823.51%-96.11%11.18%8.67%-4.09%-2.48%6.58%13.41%18.08%0.26%20.3%20.64%10.01%-9.85%31.11%15.69%28.96%-21.19%18.84%64.38%996.39%-245.83%-220%
Net Income (Continuing)449.25M642.63M637.83M642.23M707.75M692.84M521.57M592.2M593.79M20.31M521.5M469.05M431.62M450M461.44M432.97M381.76M323.31M322.48M268.07M222.2M201.97M224.05M170.89M152.22M114.54M156.11M122.3M74.4M-8.3M19.9M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)5.4710.7610.7110.8411.7311.178.368.697.650.256.415.655.075.205.194.694.063.343.212.622.131.741.821.341.090.831.060.920.57-0.07-0.02
EPS Growth %-28.58%0.47%-1.2%-7.59%5.01%33.61%-3.8%13.59%2960%-96.1%13.45%11.44%-2.5%0.19%10.66%15.52%21.56%4.05%22.52%23%22.41%-4.4%35.82%22.94%31.33%-21.7%15.22%61.4%900.56%-256%-300%
EPS (Basic)-10.8010.7510.8711.8011.258.408.767.710.256.465.705.125.275.254.774.133.373.252.672.161.771.871.391.130.881.140.990.61-0.07-0.02
Diluted Shares Outstanding82.14M59.71M59.55M59.27M60.33M62.03M62.41M68.17M77.62M80.6M81.42M83.09M85.15M86.55M88.98M92.33M94.06M96.86M100.56M102.5M104.24M115.94M123.07M127.58M135.76M137.51M136.74M132.63M119.72M116.51M120M
Basic Shares Outstanding82.14M59.51M59.33M59.08M59.98M61.58M62.09M67.63M76.99M79.79M80.79M82.34M84.36M85.43M87.84M90.83M92.39M95.8M99.2M100.5M102.69M114.02M119.64M123.19M130.49M130.56M127.57M123.01M119.72M116.51M120M
Dividend Payout Ratio-------------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Geopolitical exposure and margin volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Faces Cyclical Headwinds

According to recent financial disclosures, Waters Corporation experienced a significant revenue surge to $1.3 billion in 2026Q1, yet this follows a period of inconsistent growth where quarterly revenue fluctuated between $636.8 million and $932.4 million, suggesting that organic growth remains highly sensitive to pharmaceutical capital expenditure cycles.

The recent revenue spike appears to be an outlier rather than a sustained trend, likely driven by lumpy instrument placements rather than underlying demand acceleration. Investors should monitor whether this growth can be maintained, as historical data indicates that the company's reliance on international markets, particularly China, introduces significant volatility into the top-line trajectory.

Structural Margin Compression Warrants Caution

As reported in the latest income statement, Waters saw gross margins contract sharply to 47.0% in 2026Q1, a notable departure from the historical range of 58% to 61% observed throughout 2024 and 2025, indicating potential pricing pressure or unfavorable shifts in the product mix.

The sudden erosion of gross margins suggests that the company's premium positioning may be under threat from increased competition or rising input costs that cannot be fully passed on to customers. This compression warrants further investigation into whether the shift toward large-molecule characterization tools is diluting the historically high-margin consumables business.

Operating Leverage Turns Negative Recently

Based on the provided income statement data, Waters' operating income plummeted to a loss of $47.0 million in 2026Q1, representing a stark reversal from the 33.3% operating margin achieved in 2025Q4 and highlighting a failure to scale SG&A expenses efficiently during periods of revenue volatility.

The inability to maintain positive operating margins during the most recent quarter suggests that the company's high fixed-cost structure, particularly its specialized sales and service force, may be creating significant earnings drag. Investors should consider whether this indicates a structural inefficiency or merely a temporary misalignment of cost management relative to current revenue levels.

Sustainability of Premium Valuation Challenged

While the company has historically maintained a strong competitive moat through its Empower software ecosystem, the recent 2026Q1 net loss of $72.0 million, as documented in financial filings, raises serious questions regarding the sustainability of its premium valuation relative to more diversified peers like Agilent or Thermo Fisher.

Short-sellers may focus on the potential for permanent margin erosion if the company is forced to compete on price rather than its traditional workflow value proposition. The recent performance suggests that the 'lock-in' effect may be less defensive than previously assumed, especially if regulatory scrutiny or technological shifts allow customers to migrate to more flexible, vendor-neutral platforms.

WAT — Frequently Asked Questions

Quick answers to the most common questions about buying WAT stock.

What was Waters Corporation's (WAT) revenue in 2025?

For fiscal year 2025, Waters Corporation (WAT) reported total revenue of $3.17B. This represents a 709.3% increase compared to $391.1M in 1996.

Is Waters Corporation (WAT) profitable?

Waters Corporation (WAT) is profitable, generating $642.6M in net income for the fiscal year ending 2025 with a net profit margin of 20.3%.

What is Waters Corporation's operating profit margin?

Waters Corporation (WAT) reported an operating income of $893.2M, resulting in an operating profit margin of 28.2%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Waters Corporation's gross profit and gross margin?

Waters Corporation (WAT) generated $1.83B in gross profit for the year, representing a gross profit margin of 57.8%. This demonstrates the company's core pricing power and production efficiency.